Efracea

Efracea is a brand name for a topical medication containing the active ingredient doxycycline. Doxycycline is a tetracycline antibiotic. Efracea is prescribed for the treatment of inflammatory lesions (papules and pustules) of rosacea. It works by reducing inflammation, though its exact mechanism in rosacea is not fully understood. It is thought to have anti-inflammatory effects beyond its antibiotic properties.

The medication is typically available as an oral capsule and should be taken as directed by a healthcare professional. It is important to swallow the capsules whole and not to crush or chew them. Efracea is generally taken once daily. It is not intended for the treatment of the persistent facial erythema (redness) associated with rosacea.

Common side effects of Efracea can include diarrhea, nausea, vomiting, and abdominal pain. More serious side effects, though less common, may include severe skin reactions, yeast infections, and photosensitivity. Patients should be advised to avoid excessive sun exposure while taking this medication as it can increase the risk of sunburn.

Efracea should not be used by individuals with a known hypersensitivity to doxycycline or other tetracyclines. It is also contraindicated in pregnant or breastfeeding women and in children. As with any medication, it is crucial to discuss potential risks and benefits with a doctor before starting treatment. The duration of treatment is determined by the prescribing physician based on the patient's response and the severity of their condition.